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Abstract
Meta-analysis is a statistical methodology that combines or integrates the results of
several independent clinical trials considered by the analyst to be ‘combinable’ (Huque
1988). However, completeness and user-friendliness are uncommon both in specialised
meta-analysis software packages and in mainstream statistical packages that have to rely
on user-written commands. We implemented the meta-analysis methodology in an Mi-
crosoft Excel add-in which is freely available and incorporates more meta-analysis models
(including the iterative maximum likelihood and profile likelihood) than are usually avail-
able, while paying particular attention to the user-friendliness of the package.
Keywords: meta-analysis, forest plot, Excel, VBA, maximum likelihood, profile likelihood.
1. Introduction
Meta-analysis can be defined as the statistical analysis of a large collection of analysis results
from individual studies - usually Randomised Controlled Trials (RCTs) - for the purpose of
integrating the findings (Glass 1976). Although the debate regarding the quality and ap-
plication caveats of the method is ongoing (Egger and Smith 1997; Bailar 1997), a Medline
(http://medline.cos.com/) search by the authors reveals that the number of meta-analysis
studies published in peer-reviewed journals seems to be growing exponentially (Figure 1).
Published meta-analysis studies (search criterion: Publication Type=meta-analysis) have
risen from 274 in 1990 to 2138 in 2005, while published work that is either a meta-analysis
or deals with meta-analysis issues (search criterion: Keyword=meta-analysis) has increased
from 329 to 3350, in the same period.
A major issue in meta-analysis is the almost inevitable clinical or methodological heterogene-
ity among the combined studies (Eysenck 1994). If the study results differ greatly (large
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year meta-anayses about meta-analysis diff
1990 274 329 55
1991 333 427 94
1992 371 528 157
1993 323 538 215
1994 386 675 289
1995 428 771 343
1996 481 833 352
1997 596 1083 487
1998 639 1122 483
1999 739 1303 564
2000 849 1654 805
2001 951 1779 828
2002 1085 1908 823
2003 1298 2253 955
2004 1621 2596 975










1990 1993 1996 1999 2002 2005
Publication type: meta-analysis
Keyword: meta-analysis (including meta-analysis studies)
Figure 1: Number of meta-analysis publications (Medline search).
heterogeneity) then it may not be appropriate to combine them, since an estimate of overall
effect in such a case is of questionable value (Egger, Smith, and Phillips 1997; Thompson
1994). Nevertheless, the statistical error that stems from this between-study diversity can be
quantified and modelled (Higgins and Thompson 2002; DerSimonian and Laird 1986), and a
meta-analysis on carefully selected Randomised Controlled Trials, in terms of compatibility,
is the next best thing to a new large and expensive, prohibitively so in many cases, RCT.
Although SAS (SAS Institute Inc 2003), Stata (StataCorp. 2007), and SPSS (SPSS Inc 2006) do
not include embedded meta-analysis commands, some user-written commands and/or macros
exist that deal with this shortcoming - some more successfully than others (Egger, Sterne, and
Smith 1998). Alternatively, a researcher may use more user-friendly specialist meta-analysis
software packages, like MetaWin (Rosenberg, Adams, and Gurevitch 2007), the free but
potent RevMan (The Cochrane Collaboration 2008) or the new, promising and also free MIX
(Bax, Yu, Ikeda, Tsuruta, and Moons 2006). However, in most of the above, the outcomes
of the included studies that will be ‘fed’ into the models must all be expressed in identical
format (eg group means and standard deviations; odds ratios and sample sizes) for all the
studies. Therefore, the researcher must go through a preliminary process of transforming
study outcomes that may have been disseminated using a variety of statistical parameters (eg
means and SDs; t-values; p-values) to the common format, a tedious task that requires at
least some statistical adeptness.
Since the meta-analyst will often use a spreadsheet to summarise the reported study out-
comes and other details, in order to better organise the analysis, we developed an add-in for
Microsoft Excel that automates many meta-analysis processes and provides support for the
task. The first purpose of our software is to calculate an effect size and its standard error,
from the specific combination of input parameters supplied by the user for each outcome,
using one of the methods described by the Cochrane Collaboration (Higgins and Green 2006).
The methods that can be used with each set of input parameters are automatically identified
and the one that produces the most precise estimate of the effect is selected. Following that,
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a forest plot is created (Lewis 2001) summarising all the outcomes organised by study. Fi-
nally, various meta-analysis models, the more advanced of which (maximum likelihood, profile
likelihood and permutations method) are not available in any other meta-analysis software
package even though they have been proved to be more robust for normally distributed effects
(Brockwell and Gordon 2001; Follmann and Proschan 1999), are used to calculate an overall
mean effect and its variance. Results of the models are displayed in a second forest plot, while
a variety of heterogeneity measures are provided to help the user decide on the appropriate
model for the analysis at hand.
2. Data entry
After the add-in has been installed a meta-analysis menu will be available on the Microsoft
Excel menu-bar. Once the worksheets have been formatted using the Format Sheets com-
mand, data can be entered on the first sheet (Figure 2) - a maximum of 10 meta-analyses can
be accommodated in a workbook but we will refer to a single one for simplicity. The fields
on the data-entry worksheet are described in Table 1.
Figure 2: Data sheet.
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Figure 3: Meta-analysis add-in menu.
Once data has been inputted all processes are executed by selecting one of the two available
meta-analysis options that will be explained in more detail later: Include all secondary
outcomes or Secondary only when no primary ones (Figure 3).
Name Label Type Required Information
Study The name of thestudy String Yes
Only needs to be inputted once for
each study (in the first outcome
row). If the colour background of
a cell on that column is set to red,
the row/outcome is not included in
the analysis
Design




Only needs to be inputted once
for each study (in the first out-
come/variable row)
Variables Outcome variablenames String Yes
Truncated to 28 characters in
graphs. It is advised to set the
names of primary outcomes in bold
and those of secondary outcomes in
italics. Outcomes with names in







Not used in any of the methods, col-
umn provided for information pur-






NCb Control group size,before treatment Integer –
Not used in any of the methods, col-
umn provided for information pur-
poses and/or future use
NCa Control group size,after treatment Integer Yes
N (tot)b NIb + NCb Integer –
Not used in any of the methods, col-
umn provided for information pur-
poses
table continued to next page
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Name Label Type Required Information
N (tot)a NIa + NCa Integer –
Not used in any of the methods, col-
umn provided for information pur-
poses
Ib




Not used in any of the methods, col-
umn provided for information pur-
poses and/or future use
Ia









Not used in any of the methods, col-
umn provided for information pur-
poses and/or future use
Ca









Not used in any of the methods, col-
umn provided for information pur-











Not used in any of the methods, col-
umn provided for information pur-





Real Yes* (3, 4,5, 6)
SD(Ia)
Standard deviation












MD = mean(Ia) −
mean(Ca)
Real Yes* (3, 4,5, 6)
If MD has not been inputted it is
calculated by the formula. If it has,
the inputted value is used instead
(to take into account adjusted MD
values)
lCI95 (MD)
Lower limit of 95%
Confidence Interval




Upper limit of 95%
Confidence Interval








Not used in any of the methods, col-
umn provided for information pur-
poses and/or future use
table continued to next page
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Not used in any of the methods, col-
umn provided for information pur-
poses and/or future use
lCI95 (Ia)
Lower limit of 95%
Confidence Interval





Upper limit of 95%
Confidence Interval





Lower limit of 95%
Confidence Interval





Upper limit of 95%
Confidence Interval





























Real Yes* (6, 7)
t-value




Real Yes* (6, 7)
A p-value is calculated using this
value, which always overrides an in-
putted p-value in the previous field
df
Degrees of freedom
of a two way t-test
that compares be-
tween groups
Integer Yes* (6, 7)
Degrees of freedom are automati-
cally computed (if not provided) as
NIa + NCa + 2
table continued to next page
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the means of the
two groups
Real Yes* (3)
direction Direction of the ef-fect Char Yes
Leave empty if effect favours inter-
vention. Input a single minus sign
to reverse effect, if it favours control
quality Quality of thestudy Integer No
Evaluation of each study (only needs
to be inputted once for each study)
For future use and information pur-
poses only.
subgroup Subgroup informa-tion for an outcome String No
Information on subgroup outcomes.
They are used to label outcomes in
the results.
Table 1: Fields in the data-entry worksheet. Fields marked with an asterisk are required for
an effect size calculation method or more, but not all. The method(s) involved are shown in
brackets.
3. Effect size and standard error calculation methods
A description of the eight methods that are used for the effect size and SE calculations is pro-
vided in this section, all inferred from The Cochrane Collaboration Handbook for Systematic
Reviews of Interventions version 4.2.6, Section 8.5 (Higgins and Green 2006). Methods have
been labelled 1a, 1b, 2, 3, 4, 5, 6, and 7. The first three deal with dichotomous data, the next
four with continuous and the last method applies to both types. Each method can compute
an effect size and variance from a different combination of available statistical parameters
(sample sizes, means, t-values, etc). Table 2 provides information on the specific parameters
that are needed as input for the application of each method.
The items that appear on Table 2 are described below:
 NIa is the size of the intervention group.
 NCa is the size of the control group.
 Ia is the number of events in the intervention group (always less than NIa).
 Ca is the number of events in the control group (always less than NCa).




 CI95 (OR) is the 95% Confidence Interval for the Odds Ratio (fields lCI95 (OR) and
uCI95 (OR) in the data sheet).
 MD is the means difference of the two groups, either provided or calculated with: MD =
mean(Ia)−mean(Ca).
 CI95 (MD) is the 95% Confidence Interval for the means difference (fields lCI95 (MD)
and uCI95 (MD) in the data sheet).
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Method Data type Input parameters needed Effect estimatemeasure
Priority
1a Dichotomous NIa and NCa and Ia and Ca Risk Difference D2
1b Dichotomous NIa and NCa and Ia and Ca Odds Ratio D3
2 Dichotomous NIa and NCa and OR andCI95 (OR) Odds Ratio
D1
3 Continuous NIa and NCa and MD and(CI95 (MD) or SEdiff ) Mean Difference
C3
4 Continuous NIa and NCa and MD andSD(Ia) and SD(Ca) Mean Difference
C1
5 Continuous NIa and NCa and MD andCI95 (Ia) and CI95 (Ca) Mean Difference
C2




NIa and NCa and (p-value or
(t-value and df )) Any
D4/C5
Table 2: Effect calculation methods by input parameters needed. Method priority is described
in the text.
 SEdiff is the Standard Error of Difference between the means of the two groups.
 SD(Ia) is the Standard Deviation for the intervention group.
 SD(Ca) is the Standard Deviation for the control group.
 CI95 (Ia) is the 95% Confidence Interval for the mean of the intervention group (fields
lCI95 (Ia) and uCI95 (Ia) in the data sheet).
 CI95 (Ca) is the 95% Confidence Interval for the mean of the control group (fields
lCI95 (Ca) and uCI95 (Ca) in the data sheet).
 p-value is the p-value of the test.
 t-value is the t-value of the test.
 df the degrees of freedom of the t-test.
For some outcomes enough data is provided for the application of more than one of the
methods. In such cases, the effect size and SE are calculated using all possible ‘options’
which enables the user to compare the results and the accuracy of the information supplied
by the study in question (Figure 4). Nevertheless, only one method is finally selected to
provide us with effect sizes and standard errors for the plots and the meta-analysis. The
methods have been prioritised according to expected precision: that is, the expectation that
the effect size and associated variance computed from the input data will be accurate. As
a general rule, the fewer the number of mathematical transformations involved in getting
from the ‘raw data’ to the statistical parameters used as input for the method, the higher
the expected precision. Priority orders are displayed in Table 2 (e.g., D1 refers to the first
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Figure 4: Results sheet.
choice when data is dichotomous, C3 to the third option when data is continuous etc) and
the ‘best’ available option is automatically selected. In many studies, as a result of rounding
etc the reported p-value is not very precise; therefore methods 6 and 7 are only used when no
other method can be employed. Since 1a and 1b require the exactly same input, the former
is arbitrarily prioritised over the latter, which - in effect - is never used in further analyses
but is provided for comparison. The methods are described in detail in Appendix A.
4. Results summary
Once effect sizes and standard errors have been computed, we select the most precise result
available for each outcome and summarise the results using a forest plot type graph (Figure 5).
Forest plots normally display information on a single outcome from each study along with
an overall effect estimate at the bottom of the plot. However, in our summary forest plot all
outcomes for which an effect and a SE could be computed are included, so that the reader
can perceive a general overview of all the outcomes of interest (Figure 6).
10 MetaEasy: A Meta-Analysis Add-In for Microsoft Excel
Figure 5: Forest plot on all outcomes.
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Figure 6: Summary sheet.
5. Meta-analysis methods overview
A primary concern for meta-analysts is statistical heterogeneity in true effect size across the
studies included in an analysis, often attributed to clinical and/or methodological diversity
(Higgins and Green 2006). More specifically, clinical heterogeneity describes variability that
arises from different populations, interventions, outcomes and follow-up times, while method-
ological heterogeneity is related to differences in trial design and quality (Thompson 1994).
If the variation among the evaluated true effects of individual studies is not above that ex-
pected by chance (homogeneity not rejected) researchers usually select the fixed-effect model
(Brockwell and Gordon 2001) to combine the separate estimates into a single result. However,
medical research studies, even into the same issue, can vary on so many factors that homo-
geneity is a rare commodity and some degree of variability between studies may be anticipated
(Thompson and Pocock 1991). The best viable approach in such cases is to summarize the
results of the heterogeneous studies using a random-effects model (DerSimonian and Laird
1986). Models of this family take into account the identified between-study variation, estimate
it and generally produce wider confidence intervals for the overall effect than a fixed-effects
analysis.
As an alternative to frequentist random-effects meta-analysis, a researcher may choose a
Bayesian approach to estimation of the between-study variance (Smith, Spiegelhalter, and
Thomas 1995; Sutton and Abrams 2001). Unlike most conventional random effects methods
Bayesian methods attempt to model the uncertainty in the between-study variance, but re-
quire specification of a prior distribution, a sometimes difficult task that is particularly crucial
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Figure 7: Models sheet.
when the number of studies included in the meta-analysis is small Lambert, Sutton, Burton,
Abrams, and Jones (2005).
We have implemented seven frequentist meta-analysis methods in the add-in, for calculating
a mean effect estimate and its confidence intervals (Figure 7): t-test (T), fixed-effects model
(FE), DerSimonian and Laird random-effects model (DL), Q-based method (Q), maximum-
likelihood random-effects model (ML), profile-likelihood random-effects model (PL) and per-
mutations method utilising a DL random-effects model (PE). Where multiple primary out-
comes are available for a study, their median is used in the models. If no primary outcomes
are available, the secondary outcomes median is used instead.
In addition, a variety of heterogeneity measures are provided to help the user decide on the
fixed or random effects approach (either DL, PL or ML; PE and T are special cases). Cochran’s
Q provides a p-value for the test of homogeneity, when compared with a χ2k−1 distribution
(Brockwell and Gordon 2001), where k is the number of studies. However the test is known to
be poor at detecting heterogeneity since its power is low when the number of studies is small
(Hardy and Thompson 1998). I2 is deemed to be more reliable in assessing inconsistency
between studies, with values of 25%, 50% and 75% corresponding to low, moderate and
high heterogeneity respectively (Higgins, Thompson, Deeks, and Altman 2003). H2M is the
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Figure 8: Forest plot on median outcomes and meta-analysis models.
only measure that is truly independent of k and it takes values in the [0,+∞) range with
0 indicating - a somewhat worrying - perfect homogeneity (Mittlbock and Heinzl 2006). It
has also been suggested that the estimate of between-study variance, τ̂2, should be reported
(Higgins and Green 2008), therefore the estimated between-study variance, where relevant to
the model, is also displayed.
The MA methods and heterogeneity measures along with certain prerequisite assumptions
are described in the following section, while the resulting forest plot (which again uses the
median for studies with multiple primary outcomes) can be observed in Figure 8.
6. Meta-analysis methods description
6.1. General
Let us consider a group of studies, whose overall effect we wish to estimate. The simplest
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way to estimate a confidence interval for the population mean is to treat the effect for each
study as a single observation from a population of studies, and apply the usual Normal or T
distribution assumptions.







where X̄ is the sample mean of the effect sizes, s their standard deviation and z, tn−1 are the
critical values for the two distributions.
This method, although simple, is thought to be deficient compared to the more advanced
techniques since it does not take into account the variances on the effect estimates within the
studies - provided they have been reported, which is not always the case. Nevertheless, it has
been evaluated as a reliable alternative in performing meta-analyses, particularly if control
for type I error rate is important (Follmann and Proschan 1999). This finding was supported
by a simulation study that compared the performance of meta-analysis methods across effects
of various distributions (Kontopantelis and Reeves 2008).
6.2. Fixed effects
If the within study variances are available, a researcher can take these into account in the
estimation of an overall effect µ and a confidence interval. The fixed-effects model assumes
that within-study variances may differ, but that there is homogeneity in effect size across all
studies. It can be defined as:
Yi = θi + ei, ei ∼ N(0, σ2i ) (3)
where, for study i: Yi is the effect size estimate, θi the true effect size and ei the random
error. Under the fixed effects approach, the true study effects are all assumed to be equal
(θi = µ, i = 1, 2, · · · , k ) and the only deviations from the true effect size occur because of
errors ei, representing the imprecision of results within each study. Those errors are assumed
to be independent and normally distributed with mean zero and variance σ2i , therefore the
estimated effect sizes Yi are also normally distributed with variance σ2i , but with mean θi.
The fixed effect estimate of the overall effect µ is usually calculated as a weighted average,











Often the homogeneity assumption is unlikely and variation in the true effect across studies
is assumed, which is attributed to differences in design, circumstances, populations of partici-
pants and dose/type of treatment offered (Van den Noortgate and Onghena 2003). Whenever
heterogeneity is identified with Cochran’s Q - test (Cochran 1937) or other appropriate statis-
tical measures like I2 or H2M , a random effects model may be preferred over the fixed effects
Journal of Statistical Software 15
model. More specifically I2 = 100
Q− df
Q
(Higgins and Thompson 2002) and H2M =
Q− df
df
(Mittlbock and Heinzl 2006) are both measures that use the relation of the between- to the
within-study variance to evaluate heterogeneity.
The random-effects approach assumes that true effects θi are normally distributed. This
incorporates a second error term in (3), which accounts for across study variability, and the
model becomes (Brockwell and Gordon 2001):
Yi = θi + ei, ei ∼ N(0, σ2i ) (5)
θi = µ+ εi, εi ∼ N(0, τ2) (6)




















. This model, by assuming that the studies
at hand are a random sample out of a population of studies and modelling the variability
between them, provides wider confidence intervals for the estimate of the overall effect and is
generally considered to be a more conservative approach than the fixed effects model (Poole
and Greenland 1999).
The variance parameter τ2, of the between studies error term εi, is a measure of the between
study heterogeneity. Since it is rarely - if ever - known, it needs to be estimated. DerSimonian
and Laird’s estimator for τ2 is the method most widely used (DerSimonian and Laird 1986).
However, the overall effect and the between study variance can also be estimated with methods
such as the simple maximum likelihood and the profile likelihood proposed by Hardy and
Thompson (Hardy and Thompson 1996). The simple maximum likelihood estimates ˆµmi and
ˆτ2mi can be obtained from the log-likelihood function in (8).











, µ ∈ < & τ2 ≥ 0 (8)
The log-likelihood function is solved iteratively for the simple maximum likelihood method,
and the estimated variances are generally more accurate than the ones provided by the DL
method. The profile likelihood method is also iterative, but provides confidence intervals for
the estimates by taking into account the fact that when estimating one parameter the other
one is also unknown and needs to be estimated as well. Computationally, it can be described
as more advanced version of maximum likelihood which converges to a solution using nested
iterations. Simulations show that this produces more accurate confidence intervals than other
methods (Kontopantelis and Reeves 2008). For more details on these methods see Brockwell
and Gordon (2001).
Another proposed random-effects method has been described by Follmann and Proschan
(1999), which we have conveniently labelled the permutations method. The method can be
described in three steps. First, a matrix of all possible combinations of study outcomes from
a meta-analysis is created by permuting the effects signs. Then the DL method is used to
compute the overall effect for each combination. Finally, using the created distribution for
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the overall effect estimate µ̂pe and the hypothesis that µ is zero, a Confidence Interval for the
overall effect is calculated. In other words, rejection (or not) of the hypothesis is decided on
the position of the observed mean estimate within the distribution.
Since more often than not Cochran’s Q-test is the main determinant in the fixed or random-
effects model selection, we also include a mixed approach that combines these two models
according to the outcome of the Q-test. If the homogeneity hypothesis is rejected, the DL
random-effects model is selected; otherwise we choose the fixed-effects model. In accordance
with Brockwell and Gordon (2001) we label this method ‘Q’. All models (except T and PE,
for which it does not apply) use the inverse variance method to calculate the overall effect
and standard error of a meta-analysis.
7. Validation
Methods and graphs were validated using eight published meta-analyses whose full datasets
were readily available (Laurant, Reeves, Kontopantelis, Hermens, Braspenning, Grol, Wens-
ing, and Sibbald 2008). Validation was performed with Stata version 9.2 (StataCorp. 2007)
and more specifically programs metan version 2.34 (Harris, Bradburn, Deeks, Harbord, Alt-
man, and Sterne 2008) and meta version 2.06 (Sharp and Stern 1997). Results agreed com-
pletely for the methods that are available in both platforms: fixed-effect model (inverse vari-
ance), random-effects model (DerSimonian and Laird, inverse variance), Cochran’s Q and I2.
Comparisons for the more advanced maximum likelihood, profile likelihood and permutation
methods could not be performed, since they are not included in any of the statistical packages
considered in this paper.
8. Using MetaEasy
The add-in is freely available for download from the National Primary Care Research and
Development Centre’s web page (http://www.npcrdc.ac.uk/) and the first author’s personal
web page (http://www.statanalysis.co.uk/). It is provided as an installer executable file,
along with a short manual and data examples. Once it has been installed a meta-analysis
menu option will always be available on the menu bar (Figure 3). The first step in creating
a meta-analysis workbook is to create and format the worksheets appropriately. This is
accomplished with the Format Sheets command which creates five worksheets for a single
meta-analysis. All data entry is done on the first sheet: the remaining four sheets are ‘locked’
and are where the results and graphs are output.
After the data has been input, obtaining the results is an one click process, using one of the two
available options: (i) include all primary and secondary outcomes in the meta-analysis models
or (ii) only include secondary outcomes where a study has no primary outcomes. Studies
frequently collect, analyse, and report data on a number of outcomes relevant to a given
meta-analysis. Usually a well-designed study provides a precise description and definition
of objectives and outcomes. This allows the outcomes to be classified as either primary or
secondary: the former address the focus of the study while the latter allow for the investigation
of subsidiary questions (Gebski, Marschner, and Keech 2002). If the study is not clear about
which outcomes were regarded primary, then they should all be treated as secondary.
In addition, the reported heterogeneity measures help the user select between the fixed-effects
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and a random-effects model. Details on the characteristics and usage of the measures have
been provided in Sections 5 and 6.
Since copying and pasting the results from Excel to a text editor is not always fully successful,
graphs and blocks of cells can be exported as Graphics Interchange Format (GIF) files using
the Export graph command. The code for this command, which can be used independently to
export any graphs and cell ranges, was obtained from various websites and authors (Staff 2004;
McRitchie, Bullen, and Peltier 2008) then edited and integrated into the add-in. However,
the code was created in the Microsoft Office 2003 suite and it has not yet been tested with
other versions.
9. Conclusions
In this article we have described an efficient way to perform meta-analyses in Excel. Some of
the advantages of our module over established statistical and meta-analysis software packages
include:
 Ease of use.
 Time saving, since effect sizes and standard errors are calculated automatically from
whatever statistical parameters are available, without the need for prior transformation
to a common metric.
 More robust calculation of the effect sizes and SE , since the ‘best’ method is automat-
ically selected.
 The extracted data from each study are easily accessible, they can be quickly edited or
corrected and the analysis repeated.
 Includes a choice of seven meta-analysis models (instead of the usual two).
 Provides three advanced methods, maximum likelihood, profile likelihood and permu-
tation, not currently available in other software packages.
 Effect sizes and standard errors can be exported for use in other MA software packages.
 Provides a descriptive forest plot allowing multiple outcomes per study.
 Provides the final forest plot with the estimated mean effect and confidence interval.
 Reports a wide range of heterogeneity measures.
 The graphs can be easily edited and exported.
 It is free (provided Microsoft Excel is available).
We will aim to provide additional tools with future versions of the module (e.g., a funnel plot,
Mantel-Haenszel method for binary data), as suggested by user feedback.
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A. Effect size and SE calculation methods









where PIa = Ia/NIa & PCa = Ca/NCa








& z = |normsinv(P/2 )|*)







Step 3 SD = SEdiff /SEeffect
Step 4 effect = RD/SD
Step 5 CI95 %(effect) = effect ± 1.96 · SEeffect
Table 3: Method 1a (based on risk difference): Dichotomous data. * Excel function normsinv
returns the inverse of the standard normal cumulative distribution and P refers to the p-value
of the test. This alternative approach is never used since it is less precise (only provided for
completeness).
Needed NIa, NCa, Ia, Ca


















upperCI95 %(Q) = Q+ 1.96 · SEdiff (Q)
lowerCI95 %(Q) = Q− 1.96 · SEdiff (Q)




upperCI95 %(effect) = upperCI95 %(Q) ·
√
3/π
lowerCI95 %(effect) = lowerCI95 %(Q) ·
√
3/π
Table 4: Method 1b (based on odds ratio): Dichotomous data. * OR cannot be computed
when NIa = Ia or NCa = Ca.
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Needed NIa, NCa, OR, CI95 %(OR)
Step 1













upperCI95 %(SMD)− lowerCI95 %(SMD)
3.92
for NIa ≥ 60 & NCa ≥ 60
otherwise SEeffect =
upperCI95 %(SMD)− lowerCI95 %(SMD)
2 · tinv(1 − 0 .95 ,NIa + NCa − 2 )
*




ln OR (effect is actually the SMD)
Step 4 CI95 %(effect) = effect ± 1.96 · SEeffect
Table 5: Method 2 (based on odds ratio and its confidence interval): Dichotomous data.
* Excel function tinv returns the t-value for specific alpha and degrees of freedom.
Needed NIa, NCa, MD , CI95 %(MD)*
Step 1
SEdiff (MD) =
upperCI95 %(MD)− lowerCI95 %(MD)
3.92
for NIa ≥ 60 & NCa ≥ 60
otherwise SEdiff (MD) =
upperCI95 %(MD)− lowerCI95 %(MD)
2 · tinv(1 − 0 .95 ,NIa + NCa − 2 )
†







Step 3 SD = SEdiff /SEeffect
Step 4 effect = MD/SD
Step 5 CI95 %(effect) = effect ± 1.96 · SEeffect
Table 6: Method 3 (based on mean difference and its confidence interval): Continuous data.
* Instead of the CI95 %(MD) the SEdiff (MD) may be provided instead. † Excel function tinv
returns the t-value for specific alpha and degrees of freedom.
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Needed NIa, NCa, MD , SD(Ia), SD(Ca)*
Step 1 SD =
√
SD(Ia)2 ·NIa + SD(Ca)2 ·NCa
NIa + NCa







Step 3 effect = MD/SD
Step 4 CI95 %(effect) = effect ± 1.96 · SEeffect
Table 7: Method 4 (based on mean difference and group variances): Continuous data. * In-
stead of SD(Ia) & SD(Ca) we may have SEM (Ia) & SEM (Ca) (Standard Error of Measure-
ment). In that case we use SEM = SD/
√
N to convert SEM values to SD ones.





upperCI95 %(Ia)− lowerCI95 %(Ia)
3.92
if NIa ≥ 60
if NIa < 60 then SD(Ia) =
√
NIa
upperCI95 %(Ia)− lowerCI95 %(Ia)






upperCI95 %(Ca)− lowerCI95 %(Ca)
3.92
if NCa ≥ 60
if NCa < 60 then SD(Ca) =
√
NCa
upperCI95 %(Ca)− lowerCI95 %(Ca)
2 · tinv(1 − 0 .95 ,NCa − 1 )
*
Step 3 SD = SEdiff /SEeffect
Step 4 effect = MD/SD
Step 5 CI95 %(effect) = effect ± 1.96 · SEeffect
Table 8: Method 5 (based on mean difference and group confidence intervals): Continuous
data. * Excel function tinv returns the t-value for specific alpha and degrees of freedom.
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Needed NIa, NCa, MD , p*
Step 1 SEdiff (MD) =
MD
tinv(p,NIa + NCa − 2)
†







Step 3 SD = SEdiff /SEeffect
Step 4 effect = MD/SD
Step 5 CI95 %(effect) = effect ± 1.96 · SEeffect
Table 9: Method 6 (based on mean difference and p value): Continuous data. * A t-value
and the degrees of freedom may be used instead of the p-value (in cases where comparison
between groups was performed using a t-test). † Excel function tinv returns the t-value for
specific alpha and degrees of freedom.
Needed NIa, NCa, p*
Step 1 z = |normsinv(p/2 )|†







Step 3 effect = z · SEeffect
Step 4 CI95 %(effect) = effect ± 1.96 · SEeffect
Table 10: Method 7 (based on p value): Continuous or dichotomous data. * A t-value and the
degrees of freedom may be used instead of the p-value (in cases where comparison between
groups was performed using a t-test). † Excel function normsinv returns the inverse of the
standard normal cumulative distribution.
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